Tilray Shares Face Mounting Pressure Despite Earnings Beat

Underlying Weaknesses Emerge in Financial Metrics

Tilray’s stock continues to face significant downward momentum as selling pressure intensifies. The cannabis company’s shares are trending lower even after reporting unexpectedly positive quarterly results, with the decline accompanied by a substantial drop in trading activity.

While surface-level results for Q1 fiscal year 2026 appeared promising, deeper analysis reveals concerning financial health indicators. Tilray reported net revenues of approximately $210 million alongside a surprising net profit of $1.5 million, exceeding analyst expectations.

However, critical performance metrics tell a different story:

• Return on Equity: -85.7%
• Net Margin: -258.54%
• Q1 FY26 Net Income: $1.5 million
• Earnings Read more...